Elizabeth Yeu, M.D. from Virginia Eye Consultants presents study results showing 94% within 0.5D residual refractive astigmatism with Cassini TCA at the ASCRS conference in New Orleans, LA
Mark Packer MD, Chief Medical Officer will highlight Cassini as core technology in today’s refractive cataract surgery ecosystem. Cassini enables seamless integration of clinic and operating suite, from preoperative diagnostics through visualization and laser applications to postoperative analysis. Cassini data demonstrate 94.0% reduction of astigmatism to target, 0.50 Diopter or less. These results help increase the adoption of premium cataract surgery and Advanced Technology IOL’s.
Internationally recognized leader in ophthalmology Mark Packer joins Cassini team to support the successful development of Cassini corneal shape analyzer for refractive-cataract surgery
“The plan that we would implement using Cassini TCA would be equal in most cases to the ORA measurement.”
Redesigned Cassini corneal shape analyzer takes refractive-cataract surgery to a next level by measuring the total corneal astigmatism and eliminating post-op surprises
Mitchell A. Jackson, MD and Mark Kontos, MD on EyewireTV discussing the importance of corneal topography and Cassini in cataract surgery.
LensAR receives FDA clearance for Streamline™, providing fully automated and customized planning and execution steps for refractive cataract surgery with the Cassini corneal shape analyzer
Cassini appears to offer very high specificity in estimating corneal keratometry and specific corneal irregularity indices, even in topographically challenging corneas such as LASIK treated, keratoconic, and cross-linked.
Cassini receives second confirmation of being one of the best technological innovations within ophthalmology
Independent judging panel ranks Cassini as the #2 Innovation in Ophthalmology of 2014 from over 35 products nominated.